human | Q5 |
P496 | ORCID iD | 0000-0001-7464-0324 |
P1153 | Scopus author ID | 7401466555 |
P69 | educated at | Karolinska Institutet | Q219564 |
P108 | employer | Karolinska Institutet | Q219564 |
Karolinska University Hospital | Q1734280 | ||
P734 | family name | Bell | Q1444604 |
P735 | given name | Max | Q16422172 |
Max | Q16422172 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q57322465 | Acute Kidney Injury: New Concepts, Renal Recovery |
Q57322420 | Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death |
Q43796128 | Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications |
Q35240791 | Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury |
Q38600681 | Assessment of plasma endostatin to predict acute kidney injury in critically ill patients |
Q48012925 | Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction |
Q57322402 | Authors’ Response |
Q57322471 | Coeliac disease and risk of sepsis |
Q93074830 | Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System |
Q44096026 | Continuous renal replacement therapy in septic patients: is it really harmful? |
Q44538513 | Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure |
Q46035997 | Cystatin C is correlated with mortality in patients with and without acute kidney injury. |
Q47756154 | Cystatin C: More than a renal function marker |
Q33753800 | Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury |
Q38117663 | Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines |
Q57322476 | End-stage renal disease patients on renal replacement therapy in the intensive care unit: Short- and long-term outcome* |
Q35687637 | Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study |
Q34552610 | Findings of the first consensus conference on medical emergency teams |
Q94548676 | Hypothermia during CRRT, a comparative analysis |
Q43990833 | ICU admittance by a rapid response team versus conventional admittance, characteristics, and outcome |
Q48160781 | Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils |
Q48247147 | Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients |
Q47418657 | Intra-day variability of cystatin C, creatinine and estimated GFR in intensive care patients |
Q39942827 | Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: An observational study |
Q40945062 | LiFe: a liver injury score to predict outcome in critically ill patients |
Q50763067 | Limitations of medical treatment among patients attended by the rapid response team |
Q36242756 | Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease |
Q37957191 | Long-term outcome after acute renal replacement therapy: a narrative review |
Q36392776 | Long-term outcome after intensive care: can we protect the kidney? |
Q57322369 | National Early Warning Score vs Rapid Response Team criteria-Prevalence, misclassification, and outcome |
Q43097129 | Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury |
Q38050719 | Novel biomarkers of acute kidney injury and failure: clinical applicability |
Q45186976 | Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria |
Q48495335 | Pheochromocytoma-Induced Inverted Takotsubo-Like Cardiomyopathy Leading to Cardiogenic Shock Successfully Treated With Extracorporeal Membrane Oxygenation |
Q36460290 | Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients |
Q44118869 | Prevalence and sensitivity of MET-criteria in a Scandinavian University Hospital |
Q51590959 | Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. |
Q44871156 | Reducing in-hospital cardiac arrests and hospital mortality by introducing a medical emergency team |
Q46268130 | Renal support in critically ill patients with acute kidney injury. |
Q40160349 | Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU. |
Q57322375 | The Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot Setting |
Q57322439 | The authors reply |
Q44528542 | The deteriorating ward patient: a Swedish-Australian comparison |
Q90441471 | The impact of patient sex on intensive care unit admission: a blinded randomized survey |
Q36401899 | The influence of gender on ICU admittance |
Q43413693 | Time dependent influence of host factors on outcome after trauma |
Q41023718 | Understanding renal recovery. |
Search more.